SV Health Investors’s Asensus Surgical, Inc. ASXC Stock Holding History

SV Health Investors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$229K	Hold	510,142	–	–	0.71%	4
2022 Q2	$203K	Hold	510,142	–	–	0.46%	5
2022 Q1	$319K	Hold	510,142	–	–	0.39%	5
2021 Q4	$566K	Hold	510,142	–	–	0.37%	6
2021 Q3	$944K	Hold	510,142	–	–	0.46%	8
2021 Q2	$1.62M	Hold	510,142	–	–	0.7%	7
2021 Q1	$1.66M	Hold	510,142	–	–	0.62%	8
2020 Q4	$319K	Hold	510,142	–	–	0.15%	9
2020 Q3	$177K	Hold	510,142	–	–	0.09%	10
2020 Q2	$276K	Hold	510,142	–	–	0.19%	10
2020 Q1	$179K	Hold	510,142	–	–	0.15%	10
2019 Q4	$750K	Buy	510,142 +1	+0%	+$3	0.45%	10
2019 Q3	$4.11M	Hold	510,141	–	–	2.89%	7
2019 Q2	$9.02M	Hold	510,141	–	–	6.05%	6
2019 Q1	$15.8M	Hold	510,141	–	–	9.26%	5
2018 Q4	$15M	Hold	510,141	–	–	9.23%	5
2018 Q3	$38.5M	Sell	510,141 -70,374	-12%	-$4.76M	11.26%	4
2018 Q2	$32.9M	Hold	580,515	–	–	15.11%	3
2018 Q1	$12.8M	Hold	580,515	–	–	9.62%	4
2017 Q4	$14.6M	Hold	580,515	–	–	7.69%	5
2017 Q3	$10.8M	Hold	580,515	–	–	8.18%	4
2017 Q2	$5.36M	Hold	580,515	–	–	5.77%	4
2017 Q1	$9.13M	Hold	580,515	–	–	10.08%	4
2016 Q4	$9.81M	Hold	580,515	–	–	8.26%	5
2016 Q3	$12.8M	Hold	580,515	–	–	9.8%	4
2016 Q2	$9.21M	Hold	580,515	–	–	9.3%	4
2016 Q1	$32.1M	Hold	580,515	–	–	23.96%	2
2015 Q4	$18.7M	Hold	580,515	–	–	15.05%	3
2015 Q3	$17.1M	Hold	580,515	–	–	9.54%	5
2015 Q2	$22.6M	Hold	580,515	–	–	8.67%	5
2015 Q1	$22.1M	Hold	580,515	–	–	7.31%	4
2014 Q4	$22M	Hold	580,515	–	–	10.96%	3
2014 Q3	$32.9M	Hold	580,515	–	–	16.42%	3
2014 Q2	$38M	Buy	+580,515	New	+$33.5M	21.36%	2

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SV Health Investors's ASXC Position: Q3 2022 in Review

SV Health Investors held its Asensus Surgical, Inc. (ASXC) position steady in Q3 2022 at 510,142 shares worth $229K. The position accounts for 0.71% of the portfolio, ranked #4.

SV Health Investors first reported a position in ASXC in Q2 2014 and has held it in 34 quarters since. The position peaked at $38.5M in Q3 2018. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

SV Health Investors held 510,142 shares of Asensus Surgical, Inc. worth $229K as of Q3 2022.
SV Health Investors left its Asensus Surgical, Inc. share count unchanged in Q3 2022.
Asensus Surgical, Inc. made up 0.71% of SV Health Investors's portfolio in Q3 2022, its #4 holding.
SV Health Investors first reported a position in Asensus Surgical, Inc. in Q2 2014 and has held it in 34 quarters since.
SV Health Investors's Asensus Surgical, Inc. position peaked at $38.5M in Q3 2018.
82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on SV Health Investors's 13F filing for Q3 2022, filed 7 Nov 2022.